The Impact of Coexistence of Smoking and Diabetes on the Coronary Artery Severity and Outcomes following Percutaneous Coronary Intervention: Results from the 1^ST Jordanian PCI Registry

Table 4

One- and 12-month cardiovascular events in diabetic-smokers compared with the 3 groups.

Clinical variable	Diabetic-smokers	Diabetic-nonsmokers	Nondiabetic-smokers	Nondiabetic-nonsmokers	value
One-month events (from admission to one month):
Mortality	4 (0.9%)	16 (1.9%)	4 (0.7%)	5 (0.9%)	0.121
Stent thrombosis	4 (0.9%)	11 (1.3%)	6 (1%)	3 (0.6%)	0.559
Readmission for ACS	7 (1.5%)	22 (2.6%)	11 (1.9%)	5 (0.9%)	0.128
Coronary revascularization	5 (1.1%)	13 (1.6%)	8 (1.4%)	4 (0.7%)	0.579
Major bleeding	3 (0.6%)	15 (1.8%)	3 (0.05%)	6 (1.1%)	0.249
12-month events:
All-cause mortality	9 (1.9%)	29 (3.5%)	9 (1.5%)	11 (2%)	0.626
Stent thrombosis	13 (2.8%)	28 (3.4%)	17 (2.9%)	12 (2.2%)	0.152
Readmission for ACS	14 (3%)	35 (4.2%)	16 (2.7%)	13 (2.4%)	0.623
Coronary revascularization	12 (2.6%)	19 (2.3%)	10 (1.7%)	7 (1.3%)	0.159
Major bleeding	11 (2.4%)	29 (3.5%)	6 (1%)	4 (0.7%)	0.046